shikimic acid has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; He, C; Li, Z; Liu, W; Lu, F; Pu, Y; Shao, Q; Yin, D | 1 |
1 other study(ies) available for shikimic acid and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Shikimic Acid Promotes Oligodendrocyte Precursor Cell Differentiation and Accelerates Remyelination in Mice.
Topics: Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Demyelinating Diseases; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Female; Mice, Inbred C57BL; Myelin Basic Protein; Neuroprotective Agents; Oligodendrocyte Precursor Cells; Rats; Remyelination; Shikimic Acid; TOR Serine-Threonine Kinases | 2019 |